Scientists discovered than an enzyme called lysostaphin is able to specifically target and kill the MRSA pathogen, suggesting it could hold potential as a new treatment option.
New research has suggested that an inherited genetic trait appears to protect some individuals against MRSA infections.
To round up 2018, we asked our Expert panel to choose their top papers from across the year. Here, you can discover the articles they selected and read about and the reasons why!
Small molecules that block bacterial toxin formation have shown promise against Gram-positive bacteria in mouse models.
Researchers from Purdue University have reported that antimicrobial photodynamic therapy using a fluorescent analog of heme, could be an alternative for treating MRSA infections.
Learn more about the top news stories of the week in our round-up, including the latest research on influenza, and new findings in MRSA infection.
Researchers have revealed that frequent recurrences of MRSA infection in mouse models may be due to bacterial toxins that ‘kill’ lymphatic muscle cells, effectively impairing their ability to pump lymphatic fluid to the lymph nodes.
Mark Blaskovich gives us his thoughts on a recent study he led, published in Nature Communications, where the team re-engineered existing antibiotics to make them more powerful.
DNA sequencing of MRSA could help identify patients who are most at risk of death from the infection – providing a new treatment strategy towards personalized medicine.
New research investigating the evolutionary origins of MRSA has suggested strains may have emerged long before methicillin was used in clinical practice.